1. Scrip
  2. >>Focus On Asia

Sputnik V Cleared in India, Trajectory Against Variants May Be Key

 
• By Anju Ghangurde

India clears Russian vaccine for restricted use, adding a third vaccine to its arsenal in the fight against COVID-19. One local expert highlights the vaccine’s “clever design” amid hopes that it will hold good against variants as well.

Sputnik V name in blur. Scientist holding the glass vial with Russian vaccine.
Sputnik V gets India go-ahead • Source: Shutterstock

Russia’s Sputnik V vaccine against coronavirus has been green-lighted in India for restricted use in an emergency situation, joining two other similarly registered vaccines already deployed in the country, that’s now tackling a ferocious surge in COVID-19 cases.

Dr. Reddy's Laboratories Ltd

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from India

More from Focus On Asia

Multiple Launches Help Lilly’s Japan Growth

 
• By Ian Haydock

Lilly saw solid growth for its business in Japan last year on the back of several new launches and is building its obesity and Alzheimer's portfolios in the country.

China Biopharma Podcast

 
• By Dexter Jie Yan and Xu Hu

Join our China-based editors Dexter Yan and Xu Hu in this Chinese-language podcast looking at some of their recent interviews and other key coverage.

Celltrion Sees Multiple Biosimilar Opportunities From Trump’s Pricing EO

 
• By Jung Won Shin

Biosimilars giant Celltrion tells shareholders there could be multiple opportunities for its business under US President Donald Trump’s latest executive order on drug pricing.